Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a …

S Toback, E Galiza, C Cosgrove, J Galloway… - The Lancet …, 2022 - thelancet.com
Background The safety and immunogenicity profile of COVID-19 vaccines when
administered concomitantly with seasonal influenza vaccines have not yet been reported …

Venetoclax retreatment of patients with chronic lymphocytic leukemia after a previous venetoclax-based regimen

MC Thompson, RA Harrup, CC Coombs… - Blood …, 2022 - ashpublications.org
COI notes: MCT has received honorarium from: MJH Life Sciences, Curio Science,
VJHemOnc, Brazilian Association of Hematology and Hemotherapy (ABHH) and …

Patient safety and estimation of renal function in patients prescribed new oral anticoagulants for stroke prevention in atrial fibrillation: a cross-sectional study

PK MacCallum, R Mathur, SA Hull, K Saja, L Green… - BMJ open, 2013 - bmjopen.bmj.com
Objective In clinical trials of dabigatran and rivaroxaban for stroke prevention in atrial
fibrillation (AF), drug eligibility and dosing were determined using the Cockcroft-Gault …

Anti‐CD20 monoclonal antibodies and their use in adult autoimmune hematological disorders

D Dierickx, A Delannoy, K Saja… - American journal of …, 2011 - Wiley Online Library
Autoimmune hematological disorders encompass a broad group of hematological
conditions characterized by the loss of self‐tolerance to a variety of antigens. Despite good …

Current surgical therapy for bronchiectasis

M Ashour, K Al-Kattan, MA Rafay, KF Saja… - World journal of …, 1999 - Springer
The ideal classification system for bronchiectasis continues to be debated. As an alternative
to the present morphologic classification, a hemodynamic-based functional classification is …

[HTML][HTML] A three-year prospective study of the presentation and clinical outcomes of major bleeding episodes associated with oral anticoagulant use in the UK …

L Green, J Tan, JK Morris, R Alikhan, N Curry… - …, 2018 - ncbi.nlm.nih.gov
The outcomes of patients developing major bleeding while on oral anticoagulants remain
largely unquantified. The objectives of this study were to:(i) describe the burden of major …

Preventing strokes in people with atrial fibrillation by improving ABC

JK Chahal, S Antoniou, M Earley, S Ali… - BMJ Open …, 2019 - bmjopenquality.bmj.com
Nationally, anticoagulation for atrial fibrillation (AF) is improving but remains characterised
by marked provider variation. Uncontrolled blood pressure and coronary artery disease …

Haematological management of major bleeding associated with direct oral anticoagulants–UK experience

L Green, J Tan, S Antoniou, R Alikhan… - British journal of …, 2019 - Wiley Online Library
The lack of antidotes for activated factor X‐inhibitor direct oral anticoagulants (DOAC s)
means that management of bleeding consists largely of existing supportive therapies. This …

Sweet syndrome as terminal event in ruxolitinib-treated myelofibrosis.

B Chatterjee, U Rqieh, P Greaves… - British Journal of …, 2015 - search.ebscohost.com
The article presents a case study of a 77-year-old woman with post-essential
thrombocythaemia myelofibrosis was admitted to hospital with general deterioration. She …

Addendum to the guideline on the peri‐operative management of anti‐coagulation and anti‐platelet therapy.

K Saja - British Journal of Haematology, 2022 - search.ebscohost.com
Abstract Keywords: CrCl; DOAC; interruption; peri-operative procedure EN CrCl DOAC
interruption peri-operative procedure 188 189 2 04/19/22 20220415 NES 220415 DIRECT …